Approval · Notice of Compliance 9001 · 2007
ANDRODERM: Notice of Compliance 9001
Issued August 29, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9001
- Date
- August 29, 2007
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph class labelling update
- Therapeutic class
- Androgens
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANDRODERM | Not yet assigned | — |
Medicinal ingredients
- TESTOSTERONE 12.2 MG per PATCH
- TESTOSTERONE 24.3 MG per PATCH